Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$256.56 - $292.34 $184,723 - $210,484
720 New
720 $200,000
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $164,704 - $207,519
-850 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $14,149 - $18,452
-50 Reduced 5.56%
850 $241,000
Q1 2021

May 12, 2021

SELL
$242.95 - $284.63 $2.66 Million - $3.12 Million
-10,965 Reduced 92.41%
900 $252,000
Q1 2021

May 11, 2021

BUY
$242.95 - $284.63 $2.66 Million - $3.11 Million
10,940 Added 1182.7%
11,865 $3.03 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $21,263 - $32,006
90 Added 10.78%
925 $226,000
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $15,356 - $17,731
58 Added 7.46%
835 $237,000
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $6,721 - $8,526
25 Added 3.32%
777 $246,000
Q4 2019

Feb 13, 2020

BUY
$220.06 - $304.07 $165,485 - $228,660
752 New
752 $223,000
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $174,619 - $221,174
-627 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$293.51 - $383.83 $184,030 - $240,661
627 New
627 $222,000
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $165,702 - $234,358
-637 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$307.64 - $344.58 $195,966 - $219,497
637
637 $203,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Tiemann Investment Advisors, LLC Portfolio

Follow Tiemann Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiemann Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiemann Investment Advisors, LLC with notifications on news.